Core Stabilization Training in Juvenile Spondyloarthropathy
Launched by ISTANBUL UNIVERSITY - CERRAHPASA · Aug 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific type of exercise program called core stabilization training on children with a condition known as juvenile spondyloarthropathy, which is a type of inflammatory arthritis. The goal is to see if this exercise approach can help reduce pain, improve physical function, decrease fatigue, and enhance overall quality of life compared to a regular daily physical activity program. By understanding which type of exercise is more effective, the researchers hope to provide better treatment options for children with this condition.
To participate in the study, children aged 10 to 18 who have been diagnosed with spondyloarthritis as part of juvenile idiopathic arthritis (JIA) can apply, provided they have stable disease symptoms and no other serious health issues that could affect their ability to exercise. Participants should also be able to understand and engage in the rehabilitation program. Those who have heart problems, been in a rehab program recently, or have changing medical treatments will not be included. Throughout the study, participants will take part in supervised exercises and will be monitored to see how their health improves.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • "According to the International League of Associations for Rheumatology criteria, individuals aged 10-18 diagnosed with spondyloarthritis within the JIA subgroup will be included.
- • Only cases with stable disease activity and without additional neurological or orthopedic conditions will be considered.
- • Participants must also possess the cognitive ability to engage in active rehabilitation.
- Exclusion Criteria:
- • Individuals with a cardiovascular disease that impedes exercise
- • those who have participated in a rehabilitation program within the last 6 months
- • cases with variable medical treatment will be excluded.
About Istanbul University Cerrahpasa
Istanbul University - Cerrahpasa is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a focus on innovative clinical trials, the university harnesses cutting-edge methodologies to address pressing health challenges. Its collaborative environment fosters interdisciplinary research, enabling the development of effective therapeutic strategies and enhancing patient care. The institution's dedication to ethical standards and patient safety underscores its reputation as a leader in clinical research within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, Büyükçekmece, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported